Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: Transport mechanism using Caco-2 cell monolayer

The objective of the study was to determine the region of maximum permeation of salmon calcitonin (sCT) through the gastrointestinal tract and to investigate the mechanism of permeation. For regional permeability determination, male Sprague-Dawley rats (250–300 g) were anesthetized and the gastrointestinal tissues were isolated. Stomach, duodenum, jejunum, ileum, or colon tissues were mounted on Navicyte side-by-side diffusion apparatus. Salmon calcitonin solutions (50 μM in phosphate-buffered saline, pH 7.4, 37°C) were added to the donor side, and the samples were removed from the receiver compartment and analyzed by competitive radioimmunoassay (RIA). For mechanistic studies, Caco-2 cells were grown on Transwell inserts (0.4-μm pore size, 0.33 cm2 area) in a humidified 37°C incubator (with 5% CO2). Transport experiments were conducted for sCT solutions (50 μM in Dulbecco's modified eagle's medium [DMEM], pH 7.4) from the apical-to-basolateral (A-to-B) direction and B-to-A direction at 37°C and from the A-to-B direction at 4°C. Cell monolayer integrity was monitored by mannitol permeability and transepithelial electrical resistance (TEER) measurements. The permeability coefficients (× 10−9, cm/sec) for sCT through rat stomach, duodenum, jejunum, ileum, and colon tissues were 0.482±0.086, 0.718±0.025, 0.830±0.053, 1.537±0.32, and 0.934±0.15, respectively. The region of maximum sCT permeability is ileum followed by colon, jejunum, duodenum, and stomach. The permeability coefficients (× 10−6, cm/sec) for sCT through Caco-2 cell monolayer were 8.57±2.34 (A-to-B, 37°C), 8.01±1.22 (A-to-B, 4°C), and 6.15±1.97 (B-to-A, 37°C). The mechanism of its permeation is passive diffusion through the mucosa as determined from the Caco-2 monolayer permeability of sCT.

[1]  C. Beglinger,et al.  Intracolonic bioavailability of human calcitonin in man , 2005, European Journal of Clinical Pharmacology.

[2]  M. Khan,et al.  Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery. , 2004, Journal of pharmaceutical sciences.

[3]  Y. Berger,et al.  The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications , 1995, Cell Biology and Toxicology.

[4]  C. Yallampalli,et al.  Expression of calcitonin gene-related peptide receptor components, calcitonin receptor-like receptor and receptor activity modifying protein 1, in the rat placenta during pregnancy and their cellular localization. , 2003, Molecular human reproduction.

[5]  M. Khan,et al.  Oral delivery of proteins: progress and prognostication. , 2002, Critical reviews in therapeutic drug carrier systems.

[6]  M. Khan,et al.  Transport studies of insulin across rat jejunum in the presence of chicken and duck ovomucoids , 2001, The Journal of pharmacy and pharmacology.

[7]  U. Kompella,et al.  Delivery systems for penetration enhancement of peptide and protein drugs: design considerations. , 2001, Advanced drug delivery reviews.

[8]  S. Yamamoto,et al.  A novel calcitonin receptor gene in human osteoclasts from normal bone marrow , 1999, FEBS letters.

[9]  P. Sinko,et al.  Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats. , 1995, Journal of pharmaceutical sciences.

[10]  T. Fujita,et al.  Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine. , 1995, Journal of pharmaceutical sciences.

[11]  K. Antonin,et al.  Colonic absorption of human calcitonin in man. , 1992, Clinical science.

[12]  S. Lynch,et al.  Absorption of human calcitonin across the rat colon in vivo. , 1992, Clinical science.

[13]  D. Keljo,et al.  Quantitative determination of macromolecular transport rate across intestinal Peyer's patches. , 1983, The American journal of physiology.